7HQ-19539-57785
3 vaccinations
3 coded responses
26 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 283 / NC
- Registered
- 2021-07-24
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
P6Z-10956-12715
Child or adolescent in my care · Male · 2021-07-24
PAJ-31839-28532
Child or adolescent in my care · Male · 2021-07-24
YDS-23380-65408
Child or adolescent in my care · Male · 2021-07-24
UWH-20574-68797
Child or adolescent in my care · Female · 2021-07-25
S7U-13252-71836
Adult relative or friend · Male · 2021-08-17
Timeline
-
2021-07-23
Dose 1 — Pfizer-BioNTech
-
2021-07-24
Registered in v-safe
- 2021-07-24
- 2021-07-25
- 2021-07-27
-
2021-07-28
Survey response — days 1–6 daily, dose 1MedDRA: Impaired work ability, Somnolence — Feeling: FairFree text: Excessive Daytime Drowsiness and getting worse since 2nd-3rd day, in retrospect. A short nap is essential to continue with work/task.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-07-30
- 2021-08-06
- 2021-08-13
- 2021-08-20
-
2021-08-27
Dose 2 — Pfizer-BioNTech
- 2021-08-27
-
2021-08-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2021-08-29
- 2021-08-30
- 2021-09-05
-
2021-09-11
Survey response — day 14, dose 2MedDRA: Pre-existing disease, Rhinorrhoea, Self-medication — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Very Significant Rhinorrhea x 2 days.Would NOT respond to 'usual' Anti-Histamine Rx, and also Claritin-D12 PO BID.Was unprovoked, no trigger couldbe elucidated.Nasal Spray and or Steroid Inhaler helped previously, but not this time.Self-subside3rdDMedDRA releases: 2024-11 · check-in free text available
- 2021-09-17
- 2021-09-24
- 2021-10-01
- 2021-10-08
- 2021-11-27
-
2022-02-15
Dose 3 — Pfizer-BioNTech
-
2022-02-16
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue, Pre-existing disease — Feeling: Fair · Site: PainFree text: More than usual fatigue.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-17
- 2022-02-18
- 2022-02-19
- 2022-02-20
- 2022-02-25
- 2022-05-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-23 | Pfizer-BioNTech | No |
| 2 | 2021-08-27 | Pfizer-BioNTech | No |
| 3 | 2022-02-15 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Excessive Daytime Drowsiness and getting worse since 2nd-3rd day, in retrospect. A short nap is essential to continue with work/task.
Release 9 — day 14, dose 2
Symptoms: Very Significant Rhinorrhea x 2 days.Would NOT respond to 'usual' Anti-Histamine Rx, and also Claritin-D12 PO BID.Was unprovoked, no trigger couldbe elucidated.Nasal Spray and or Steroid Inhaler helped previously, but not this time.Self-subside3rdD cut off by CDC
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): More than usual fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Impaired work ability | ✓ | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Somnolence | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release